The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022 at 10:38 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Switzerland ...
